Prognostic factors in ovarian cancer: how close are we to a complete picture?
Authors:
- R. AgarwalRAR. Agarwal
- S.B. KayeSKS.B. Kaye
Open Access
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 16 (1) , 4-6
Abstract
Ovarian cancer is the fourth most common cause of cancer-related death in women, but is the most lethal of the gynaecological malignancies with 30–40% overall survival at 5 years [1]. This is in part because the majority of patients with ovarian cancer present with advanced disease, and treatment options at presentation are confined to a combination of debulking surgery and platinum based chemotherapy, which are only partially effective [2]. Consequently, almost all patients with advanced disease ultimately relapse and die of their disease. Advances in the management of these patients are therefore urgently required.Keywords
This publication has 17 references indexed in Scilit:
- Prognostic molecular markers in early breast cancerBreast Cancer Research, 2004
- Future directions in the surgical management of ovarian cancerGynecologic Oncology, 2003
- Erlotinib (Tarceva): An update on the clinical trial programSeminars in Oncology, 2003
- Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm TrialJNCI: Journal of the National Cancer Institute, 2003
- Part I: Chemotherapy for epithelial ovarian cancer–treatment at first diagnosisThe Lancet Oncology, 2002
- Efficacy and safety of Herceptin® in women with metastatic breast cancer: results from pivotal clinical studiesAnti-Cancer Drugs, 2001
- A prognostic model for ovarian cancerBritish Journal of Cancer, 2001
- The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological CancerInternational Journal of Gynecological Cancer, 1993
- An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancerBritish Journal of Cancer, 1992
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981